University of Limerick Institutional Repository

High rate of adherence to urate-lowering treatment in patients with gout: who’s to blame?

DSpace Repository

Show simple item record Perez-Ruiz, Fernando Perez-Herrero, Nuria Richette, Pascal Stack, Austin G. 2020-11-02T11:54:19Z 2020-11-02T11:54:19Z 2020
dc.description peer-reviewed en_US
dc.description.abstract Introduction: Gout is commonly associated with low adherence rates, thus limiting the effectiveness of treatment. Nevertheless, informed and empowered patients may be more likely to achieve high adherence. We intend to demonstrate that adherence in clinical practice may reach that achieved in clinical trials. Methods: This was a transversal study within an inception cohort of patients with gout prospectively followed up. Patients were informed at entrance in the cohort of outcomes, targets, and means to implement for successful treatment. Adherence was evaluated through electronic medication possession ratio (MPR) for urate-lowering medication and oral medications for hypertension, diabetes, and hyperlipidemia for comparison. Factors associated with nonadherence, and the relation between nonadherence and serum urate levels while on treatment were analyzed. Results: Data were retrieved from 336 patients, who showed a mean MPR of 87.5%, with 82.1% of patients showing MPR C 0.8. Rates of adherence for hypertension, hyperlipidemia, and diabetes were quite similar (88%, 87%, and 83%, respectively), although MPR[0.8 was significantly lower for oral medications for diabetes. Adherence was lower, but nevertheless quite fair, during the first year of follow-up, and increasing over time. Active follow-up and comorbidity were associated with good adherence, and adherence and long-term follow-up were associated with higher rates of achieving serum urate within therapeutic target. Conclusion: Patients with gout show high rates of adherence if empowered. Active follow-up and comorbidity are associated with high rates of adherence. Adherence is strongly associated with higher rates of achievement of therapeutic serum urate target. en_US
dc.language.iso eng en_US
dc.publisher Springer en_US
dc.relation.ispartofseries Rheumatology and Therapy;
dc.subject Adherence en_US
dc.subject Gout en_US
dc.subject Treatment en_US
dc.title High rate of adherence to urate-lowering treatment in patients with gout: who’s to blame? en_US
dc.type info:eu-repo/semantics/article en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.identifier.doi 10.6084/ m9.figshare.13109675
dc.contributor.sponsor Asociacio ´n de Reumato ´logos del Hospital de Cruces en_US
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


My Account